Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Challenges and perspective of cancer patients during the COVID-19 pandemic and t...
Dr Rashad Nawfal - Lebanese University, Beirut, Lebanon
Challenges and perspective of cancer patients during the COVID-19 pandemic and the Lebanese financial crisis ( Dr Rashad Nawfal - Lebanese University, Beirut, Lebanon )
24 Feb 2022
Tailoring radiation therapy in the 21st century
Prof Philip Poortmans - University of Antwerp, Antwerp, Belgium
Tailoring radiation therapy in the 21st century ( Prof Philip Poortmans - University of Antwerp, Antwerp, Belgium )
23 Feb 2022
Preventive oncology nutrition for healthy carriers and BRCA1/2 + breast cancer p...
Dr Diana Artene - American Society for Nutrition, Bucharest, Romania
Preventive oncology nutrition for healthy carriers and BRCA1/2 + breast cancer patients ( Dr Diana Artene - American Society for Nutrition, Bucharest, Romania )
23 Feb 2022
Brentuximab vedotin and CHP benefit over CHOP for CD30-positive PTCL
Dr Juliana Pereira & Dr Steven Horwitz
Brentuximab vedotin and CHP benefit over CHOP for CD30-positive PTCL ( Dr Juliana Pereira & Dr Steven Horwitz )
22 Feb 2022
International Society of Paediatric Surgical Oncology (IPSO) surgical practice g...
Dr Jaime Shalkow - National Institute of Paediatrics, Mexico City, Mexico
International Society of Paediatric Surgical Oncology (IPSO) surgical practice guidelines ( Dr Jaime Shalkow - National Institute of Paediatrics, Mexico City, Mexico )
22 Feb 2022
PET scanning in patients with classical Hodgkin lymphoma outside of Europe and N...
Prof Mark Hertzberg - University of New South Wales, Sydney, Australia
PET scanning in patients with classical Hodgkin lymphoma outside of Europe and North America ( Prof Mark Hertzberg - University of New South Wales, Sydney, Australia )
22 Feb 2022
Update: Cabozantinib plus nivolumab demonstrates continued survival benefit in a...
Dr Cristina Suárez - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spai...
Update: Cabozantinib plus nivolumab demonstrates continued survival benefit in aRCC ( Dr Cristina Suárez - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain )
21 Feb 2022
KEYNOTE 564 update: Pembrolizumab versus placebo as post-nephrectomy adjuvant th...
Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
KEYNOTE 564 update: Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for patients with renal cell carcinoma ( Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )
21 Feb 2022
ASCO GU 2022: What to watch out for in renal
Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
ASCO GU 2022: What to watch out for in renal ( Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )
21 Feb 2022
Maintenance PARP inhibition following chemotherapy for metastatic urothelial car...
Dr Simon Crabb - University of Southampton, Southampton, UK
Maintenance PARP inhibition following chemotherapy for metastatic urothelial carcinoma ( Dr Simon Crabb - University of Southampton, Southampton, UK )
21 Feb 2022
First randomized trial on adjuvant mitotane in adrenocortical carcinoma patients...
Prof Alfredo Berruti - University Of Brescia, Brescia, Italy
First randomized trial on adjuvant mitotane in adrenocortical carcinoma patients: The Adjuvo study. ( Prof Alfredo Berruti - University Of Brescia, Brescia, Italy )
21 Feb 2022
Durvalumab with olapirib shows no PFS improvement for platinum-ineligible bladde...
Prof Jonathan Rosenberg - Memorial Sloan Kettering Cancer Center, New York, USA
Durvalumab with olapirib shows no PFS improvement for platinum-ineligible bladder cancer ( Prof Jonathan Rosenberg - Memorial Sloan Kettering Cancer Center, New York, USA )
21 Feb 2022